Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 20 h ago

ARVINAS, INC.: D. E. SHAW & CO, L.P. amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

D.E. Shaw & Co., L.P. amended its Schedule 13G stake filing for Arvinas, Inc., according to an SEC filing (accession 0001104659-26-128456). The amendment updates the hedge fund's previously reported beneficial ownership position in the clinical-stage biotech. The filing did not disclose a change in share count or percentage in the headline. Investors watch 13G amendments for signals of institutional conviction in Arvinas, whose pipeline centers on targeted protein degradation.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

D. E. Shaw & Co., L.P., Arvinas, Inc.